查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2060175

動物血糖監測市場分析與預測（至2035年）：依產品、技術、組件、應用、最終使用者、功能、解決方案、設備類型、目標動物及使用方法

Veterinary Blood Glucose Market Analysis and Forecast to 2035: Product, Technology, Component, Application, End User, Functionality, Solutions, Device Type, Animal Type, Usage Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球動物血糖監測市場預計將從2025年的5億美元成長到2035年的13億美元，年複合成長率（CAGR）為9.6%。2026年，在寵物飼養量增加和照護現場診斷技術進步的推動下，動物血糖監測市場將持續擴張，因為獸醫醫院和寵物飼主擴大採用常規和連續血糖監測解決方案，以應對伴侶動物糖尿病和代謝性疾病日益成長的患病率。發表在Journal of Veterinary Internal Medicine上的臨床資料提供了明確的統計資料，支持了這項需求。資料顯示，糖尿病影響約0.2%至1%的犬和0.43%至0.58%的貓，這代表著持續存在的、具有顯著臨床意義的疾病負擔，需要定期進行血糖監測和長期管理。這種持續的流行，加上人們對早期診斷和持續監測益處的認知不斷提高，顯著推動所有獸醫機構對血糖值檢測儀、測試紙和先進的連續血糖監測系統的需求。

持續血糖監測（CGM）系統和穿戴式動物血糖監測儀正推動動物血糖監測市場快速成長，這主要得益於人們對伴侶動物即時監測、改善血糖控制和加強長期疾病管理的需求不斷成長。與間歇性檢測相比，這些技術能夠提供持續的血糖值變化趨勢，實現更精準的胰島素給藥，並減少低血糖等併發症。 MDPI 發布的2024-2025年獸醫調查有力地佐證了這一趨勢，該調查顯示，約 17.2%的獸醫已在使用持續血糖監測系統（CGMS），表明該系統正與傳統監測方法一起在臨床實踐中迅速普及。臨床應用的擴展，以及人們對先進監測益處的日益了解，加速獸用糖尿病護理領域向基於 CGM 的解決方案的轉變。

市場區隔
產品 血糖值檢測儀、測試紙、採血針、感測器、管理解決方案、其他
技術 電化學生物感測器、光學生物感測器、酵素法、其他
組件 設備、耗材、軟體和資料平台、其他
用途 糖尿病監測、低血糖檢測、高血糖監測、其他
最終用戶 動物醫院/診所、動物研究機構、居家醫療、其他
功能 即時監控、現場監控、資料追蹤和分析、其他
解決方案 血糖監測解決方案、數位健康資料分析解決方案、其他
設備類型 攜帶式血糖值檢測儀、連續血糖監測（CGM）系統、穿戴式監測設備、其他
目標動物 伴侶動物（狗、貓）、牲畜、其他
如何使用 POC檢測、家庭監測、其他

攜帶式血糖值檢測儀和測試紙憑藉其價格優勢、廣泛的臨床應用以及作為獸醫學中主要診斷和監測工具的地位，持續主導著獸醫血糖監測市場。由於其易用性和成本效益，這些設備仍然是診所和家庭日常血糖值監測的標準治療方法。持續的需求也體現在《獸醫內科雜誌》發表的流行病學資料中，資料顯示，在基層醫療機構中，約有0.43%至0.58%（約200隻貓中就有1隻）的貓患有糖尿病。這種持續的疾病盛行率直接推動了常規血糖檢測的數量，鞏固了攜帶式血糖儀和耗材在日常獸醫診斷中的主導地位。

區域概覽

北美地區憑藉其高寵物擁有率、先進的獸醫醫療基礎設施以及積極採用診斷和監測技術來管理伴侶動物慢性疾病，正引領獸醫血糖值監測市場的發展。該地區受益於獸醫服務的普及、寵物醫療保健支出的成長以及對連續監測技術的早期應用。根據美國獸醫協會（AVMA）2026年 4月的一篇報導，美國寵物飼主在寵物相關支出上的花費將超過 1,360億美元，其中大部分將用於獸醫護理和診斷。如此高的支出水準推動了常規和高級血糖監測的普及，鞏固了北美在該市場的主導地位。

亞太地區動物血糖監測市場正經歷顯著成長，這主要得益於寵物飼養量的增加、動物健康意識的提高以及中國、印度和日本等國家獸醫基礎設施的不斷完善。該地區伴侶動物數量也在快速成長，同時獸醫服務和預防性診斷的支出也在增加。聯合國糧食及農業組織（糧農組織）的資料清楚顯示了2026年的該成長趨勢，資料顯示亞洲各地的牲畜和伴侶動物數量將大幅成長，同時對動物衛生系統的投資也將增加。動物數量的成長和醫療保健服務可及性的提高共同推動了對包括血糖值監測在內的診斷工具的需求，使亞太地區成為一個快速成長的市場。

主要趨勢和促進因素

伴侶動物糖尿病盛行率的上升推動了對血糖監測的需求。

寵物（尤其是犬貓）糖尿病和代謝性疾病發病率的不斷上升，日益推動了這個市場的發展，對常規和持續血糖值監測解決方案產生了持續的需求。獸醫和寵物飼主越來越重視早期診斷和長期疾病管理，因此血糖值檢測儀、測試紙和監測設備的使用率也隨之提高。班菲爾德寵物醫院發布的《2024年寵物健康報告》中的臨床資料有力地佐證了這一趨勢。報告強調，在過去十年間，美國寵物慢性疾病（包括糖尿病）的發生率持續上升，凸顯了獸醫臨床實踐中對常規血糖監測和管理工具日益成長的需求。

獸醫學領域廣泛採用連續血糖監測（CGM）和穿戴式技術：

另一個重要因素是持續血糖監測系統和穿戴式裝置的快速普及，與傳統的間歇性檢測相比，這些裝置能夠即時追蹤血糖值，改善疾病管理。這些技術有助於更佳控制血糖，減輕動物的壓力，並透過資料驅動的治療決策改善臨床療效。美國國家生物技術資訊中心（NCBI）發表的一項臨床研究就是一個鮮明的例子。本研究表明，在糖尿病犬中，瞬時血糖監測系統提供的血糖資料遠比傳統的血液採樣方法更全面，這支持了獸醫學領域對這些技術的日益普及。

目錄

第1章 執行摘要

第2章 市場概覽

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機會
  • 市場限制因素
  • 年複合均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依設備類型分類
    • 攜帶式血糖值檢測儀
    • 連續血糖監測（CGM）系統
    • 穿戴式監測設備
    • 其他
  • 市場規模及預測：依產品分類
    • 血糖值檢測儀
    • 測試紙
    • 採血針
    • 感應器
    • 管理解決方案
    • 其他
  • 市場規模及預測：依技術分類
    • 電化學生物感測器
    • 光學生物感測器
    • 酵素法
    • 其他
  • 市場規模及預測：依應用領域分類
    • 糖尿病監測
    • 低血糖檢測
    • 高血糖監測
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 獸醫醫院和獸醫診所
    • 動物研究所
    • 居家醫療
    • 其他
  • 市場規模及預測：依動物種類分類
    • 伴侶動物（狗、貓）
    • 家畜
    • 其他
  • 市場規模及預測：依組件分類
    • 裝置
    • 消耗品
    • 軟體和資料平台
    • 其他
  • 市場規模及預測：依功能分類
    • 即時監控
    • 現場監測
    • 資料追蹤與分析
    • 其他
  • 市場規模及預測：依使用方法分類
    • 即時偵測（POC）
    • 家庭監控
    • 其他
  • 市場規模及預測：依解決方案分類
    • 血糖監測方案
    • 數位健康資料分析解決方案
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要公司的策略

第8章 公司簡介

  • Zoetis
  • IDEXX Laboratories
  • Abbott Laboratories
  • Heska Corporation
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Virbac
  • Neogen Corporation
  • Bio-Rad Laboratories
  • Randox Laboratories
  • Nova Biomedical
  • ARKRAY
  • DiaSys Diagnostic Systems
  • Roche Diagnostics
  • i-SENS
  • TaiDoc Technology Corporation
  • EKF Diagnostics
  • Trividia Health
  • Woodley Equipment Company

第9章 關於Global Insight Services

簡介目錄
Product Code: GIS26685

The global Veterinary Blood Glucose Market is projected to grow from $0.5 billion in 2025 to $1.3 billion by 2035, at a compound annual growth rate (CAGR) of 9.6%. In 2026, the Veterinary Blood Glucose market is expanding as veterinary clinics and pet owners increasingly adopt routine and continuous glucose monitoring solutions to manage rising cases of diabetes and metabolic disorders in companion animals, supported by growing pet ownership and advancements in point-of-care diagnostics; a clear stat-based instance of this demand is reflected in clinical data published in the Journal of Veterinary Internal Medicine, which reports that diabetes mellitus affects approximately 0.2%a"1% of dogs and around 0.43%a"0.58% of cats, highlighting a consistent and clinically significant disease burden that requires regular glucose monitoring and long-term management. This sustained prevalence, combined with increasing awareness of early diagnosis and continuous monitoring benefits, is significantly driving demand for blood glucose meters, test strips, and advanced continuous glucose monitoring systems across veterinary care settings.

Continuous glucose monitoring (CGM) systems and wearable veterinary glucose devices are driving the fastest growth in the Veterinary Blood Glucose market due to increasing demand for real-time monitoring, improved glycemic control, and better long-term disease management in companion animals. These technologies provide continuous glucose trends compared to intermittent testing, enabling more accurate insulin dosing and reducing complications such as hypoglycemia. A strong real-world instance is reflected in a 2024-2025 veterinary survey published in MDPI, which found that continuous glucose monitoring systems (CGMS) are already used by ~17.2% of veterinarians, indicating rapid clinical adoption alongside traditional monitoring methods. This growing clinical usage, combined with increasing awareness of advanced monitoring benefits, is accelerating the shift toward CGM-based solutions in veterinary diabetes care.

Market Segmentation
ProductBlood Glucose Meters, Test Strips, Lancets, Sensors, Control Solutions, Others
TechnologyElectrochemical Biosensors, Optical Biosensors, Enzyme-Based Detection, Others
ComponentDevices, Consumables, Software & Data Platforms, Others
ApplicationDiabetes Monitoring, Hypoglycemia Detection, Hyperglycemia Monitoring, Others
End UserVeterinary Clinics & Hospitals, Animal Research Institutes, Homecare Settings, Others
FunctionalityReal-Time Monitoring, Spot Monitoring, Data Tracking & Analytics, Others
SolutionsGlucose Monitoring Solutions, Digital Health & Data Analytics Solutions, Others
Device TypeHandheld Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Systems, Wearable Monitoring Devices, Others
Animal TypeCompanion Animals (Dogs, Cats), Livestock Animals, Others
Usage ModePoint-of-Care Testing, Home-Based Monitoring, Others

Handheld blood glucose meters and test stripa"based monitoring continue to dominate the Veterinary Blood Glucose market by share, supported by their affordability, widespread clinical use, and role as the primary diagnostic and monitoring tool in veterinary practice. These devices remain the standard of care for routine glucose monitoring in both clinics and home settings due to their ease of use and cost-effectiveness. A real-world instance of sustained demand is reflected in epidemiological data published in the Journal of Veterinary Internal Medicine, which shows that diabetes affects approximately 0.43%a"0.58% of cats (around 1 in 200 cats) in primary veterinary care populations. This consistent disease prevalence directly drives routine glucose testing volumes, reinforcing the dominance of handheld meters and consumables in day-to-day veterinary diagnostics.

Geographical Overview

North America dominates the Veterinary Blood Glucose market due to high pet ownership, advanced veterinary care infrastructure, and strong adoption of diagnostic and monitoring technologies for chronic disease management in companion animals. The region benefits from widespread availability of veterinary services, increasing spending on pet healthcare, and early adoption of continuous monitoring technologies. According to the article American Veterinary Medical Association in April 2026, which reported that U.S. pet owners spent over $136 billion on pet-related expenditures, with a significant share allocated to veterinary care and diagnostics. This high level of expenditure supports routine and advanced glucose monitoring adoption, reinforcing North America's leading position in the market.

Asia-Pacific is the significant growing region in the Veterinary Blood Glucose market, driven by rising pet ownership, increasing awareness of animal health, and expanding veterinary healthcare infrastructure across countries such as China, India, and Japan. The region is witnessing rapid growth in companion animal populations alongside increasing expenditure on veterinary services and preventive diagnostics. In 2026, a strong real-world instance of this growth is highlighted by data from the Food and Agriculture Organization, which notes the significant expansion of livestock and companion animal populations across Asia, alongside increasing investment in animal health systems. This growth in animal populations and healthcare access is driving demand for diagnostic tools, including blood glucose monitoring, positioning Asia-Pacific as the significant growing regional market.

Key Trends and Drivers

Rising Prevalence of Diabetes in Companion Animals Driving Demand for Glucose Monitoring:

The market is increasingly driven by the growing incidence of diabetes and metabolic disorders in companion animals, particularly dogs and cats, which is creating sustained demand for routine and continuous blood glucose monitoring solutions. Veterinary professionals and pet owners are placing greater emphasis on early diagnosis and long-term disease management, leading to higher adoption of glucose meters, test strips, and monitoring devices. A strong real-world instance is reflected in clinical data published in the Banfield Pet Hospital 2024 Pet Health Report, which highlights a steady rise in chronic conditions including diabetes among pets in the U.S. over the past decade, reinforcing the growing clinical need for regular glucose monitoring and management tools in veterinary practice.

Increasing Adoption of Continuous Glucose Monitoring (CGM) and Wearable Technologies in Veterinary Care:

Another key driver is the rapid shift toward continuous glucose monitoring systems and wearable devices that provide real-time glucose tracking and improved disease management compared to traditional intermittent testing. These technologies enable better glycemic control, reduce stress for animals, and improve clinical outcomes through data-driven treatment decisions. A clear real-world instance is a clinical study available on the National Center for Biotechnology Information (NCBI), which demonstrated that flash glucose monitoring systems provide significantly more comprehensive glucose data compared to traditional blood sampling methods in diabetic dogs, supporting their increasing adoption in veterinary medicine.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Device Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Animal Type
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Usage Mode
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Device Type (2020-2035)
    • 4.1.1 Handheld Blood Glucose Meters
    • 4.1.2 Continuous Glucose Monitoring (CGM) Systems
    • 4.1.3 Wearable Monitoring Devices
    • 4.1.4 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Blood Glucose Meters
    • 4.2.2 Test Strips
    • 4.2.3 Lancets
    • 4.2.4 Sensors
    • 4.2.5 Control Solutions
    • 4.2.6 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Electrochemical Biosensors
    • 4.3.2 Optical Biosensors
    • 4.3.3 Enzyme-Based Detection
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Diabetes Monitoring
    • 4.4.2 Hypoglycemia Detection
    • 4.4.3 Hyperglycemia Monitoring
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Veterinary Clinics & Hospitals
    • 4.5.2 Animal Research Institutes
    • 4.5.3 Homecare Settings
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Animal Type (2020-2035)
    • 4.6.1 Companion Animals (Dogs, Cats)
    • 4.6.2 Livestock Animals
    • 4.6.3 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Devices
    • 4.7.2 Consumables
    • 4.7.3 Software & Data Platforms
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Real-Time Monitoring
    • 4.8.2 Spot Monitoring
    • 4.8.3 Data Tracking & Analytics
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Usage Mode (2020-2035)
    • 4.9.1 Point-of-Care Testing
    • 4.9.2 Home-Based Monitoring
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Glucose Monitoring Solutions
    • 4.10.2 Digital Health & Data Analytics Solutions
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Device Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 End User
      • 5.2.1.6 Animal Type
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Usage Mode
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Device Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 End User
      • 5.2.2.6 Animal Type
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Usage Mode
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Device Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 End User
      • 5.2.3.6 Animal Type
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Usage Mode
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Device Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 End User
      • 5.3.1.6 Animal Type
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Usage Mode
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Device Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 End User
      • 5.3.2.6 Animal Type
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Usage Mode
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Device Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 End User
      • 5.3.3.6 Animal Type
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Usage Mode
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Device Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 End User
      • 5.4.1.6 Animal Type
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Usage Mode
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Device Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 End User
      • 5.4.2.6 Animal Type
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Usage Mode
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Device Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 End User
      • 5.4.3.6 Animal Type
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Usage Mode
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Device Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 End User
      • 5.4.4.6 Animal Type
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Usage Mode
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Device Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 End User
      • 5.4.5.6 Animal Type
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Usage Mode
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Device Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 End User
      • 5.4.6.6 Animal Type
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Usage Mode
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Device Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 End User
      • 5.4.7.6 Animal Type
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Usage Mode
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Device Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 End User
      • 5.5.1.6 Animal Type
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Usage Mode
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Device Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 End User
      • 5.5.2.6 Animal Type
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Usage Mode
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Device Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 End User
      • 5.5.3.6 Animal Type
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Usage Mode
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Device Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 End User
      • 5.5.4.6 Animal Type
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Usage Mode
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Device Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 End User
      • 5.5.5.6 Animal Type
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Usage Mode
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Device Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 End User
      • 5.5.6.6 Animal Type
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Usage Mode
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Device Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 End User
      • 5.6.1.6 Animal Type
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Usage Mode
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Device Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 End User
      • 5.6.2.6 Animal Type
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Usage Mode
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Device Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 End User
      • 5.6.3.6 Animal Type
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Usage Mode
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Device Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 End User
      • 5.6.4.6 Animal Type
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Usage Mode
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Device Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 End User
      • 5.6.5.6 Animal Type
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Usage Mode
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zoetis
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 IDEXX Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Abbott Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Heska Corporation
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Merck Animal Health
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Boehringer Ingelheim Animal Health
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Elanco Animal Health
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Virbac
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Neogen Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Bio-Rad Laboratories
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Randox Laboratories
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Nova Biomedical
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 ARKRAY
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DiaSys Diagnostic Systems
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Roche Diagnostics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 i-SENS
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 TaiDoc Technology Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 EKF Diagnostics
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Trividia Health
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Woodley Equipment Company
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us